Effects of switching from clopidogrel to prasugrel at the chronic phase after coronary stenting on antiplatelet action and vascular endothelial function: Switch-Pras study

Compared to clopidogrel, prasugrel has a lower incidence of ischemic events following percutaneous coronary intervention (PCI) because of an early reduction during the acute phase in P2Y12 reaction units (PRU). The objective of this study was to compare the antiplatelet effect and vascular endotheli...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Heart Vessels
Autori principali: Masuyama, Taiki, Sakuma, Masashi, Waku, Ryutaro, Hirose, Suguru, Kitahara, Keijiro, Naganuma, Jin, Yazawa, Hiroko, Toyoda, Shigeru, Abe, Shichiro, Nakajima, Toshiaki, Inoue, Teruo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Japan 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7940291/
https://ncbi.nlm.nih.gov/pubmed/33113567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00380-020-01714-w
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi